Safety and Benefit of Early Elective Percutaneous Coronary Intervention After Successful Thrombolytic Therapy for Acute Myocardial Infarction

American Journal of Cardiology

Volumn 103, Issue 10, 2009, Pages 1333-1338

  Sim, Doo Sun ^a   Jeong, Myung Ho ^a   Ahn, Youngkeun ^a   Kim, Young Jo ^b   Chae, Shung Chull ^c   Hong, Taek Jong ^d   Seong, In Whan ^e   Chae, Jei Keon ^f   Kim, Chong Jin ^g   Cho, Myeong Chan ^f   Seung, Ki Bae ^h   Park, Seung Jung ⁱ  

^a Chonnam National University Medical School   (South Korea)

^b Young Nam University Hospital   (South Korea)

^c Kyungpook National University Hospital   (South Korea)

^d Pusan National University Hospital   (South Korea)

^e Chungnam National University College of Medicine   (South Korea)

^f Chungbuk National University Hospital   (South Korea)

^g Kyung Hee University College of Medicine   (South Korea)

^h The Catholic University of Korea   (South Korea)

ⁱ Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; TENECTEPLASE; THIENOPYRIDINE DERIVATIVE; UROKINASE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLEEDING; CORONARY ARTERY BYPASS SURGERY; DEATH; FEMALE; FIBRINOLYTIC THERAPY; HEART DEATH; HEART INFARCTION; HUMAN; KOREA; LOADING DRUG DOSE; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REGISTER; REPEAT PROCEDURE; RISK BENEFIT ANALYSIS; SAFETY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; KOREA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SAFETY; STATISTICS, NONPARAMETRIC; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 65449160499     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.01.339     Document Type: Article

References (19)

1. Topol E.J., O'Neill W.W., Langburd A.B., Walton Jr. J.A., Bourdillon P.D., Bates E.R., Grines C.L., Schork A.M., Kline E., and Pitt B. A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction. Circulation 75 (1987) 420-428
2. Belenkie I., Knudtson M.L., Roth D.L., Hansen J.L., Traboulsi M., Hall C.A., Manyari D., Filipchuck N.G., Schnurr L.P., and Rosenal T.W. Relation between flow grade after thrombolytic therapy and the effect of angioplasty on left ventricular function: a prospective randomized trial. Am Heart J 121 (1991) 407-416
3. The TIMI Research Group. Immediate versus delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction: TIMI II-A results. JAMA 260 (1988) 2849-2858
4. Michels K.B., and Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates?. A quantitative overview (metaanalysis) of the randomized clinical trials. Circulation 91 (1995) 476-485
5. Le May M.R., Wells G.A., Labinaz M., Davies R.F., Turek M., Leddy D., Maloney J., McKibbin T., Quinn B., Beanlands R.S., et al. COMBINED ANgioplasty and Pharmacological Intervention vs Thrombolysis ALone in acute myocardial infarction (CAPITAL AMI study). J Am Coll Cardiol 46 (2005) 417-424
6. McClelland A.J., Owens C.G., Walsh S.J., McCarty D., Mathew T., Stevenson M., Gracey H., Khan M.M., and Adgey A.A. Percutaneous coronary intervention and 1 year survival in patients treated with fibrinolytic therapy for acute ST-elevation myocardial infarction. Eur Heart J 26 (2005) 544-548
7. Gibson C.M., Karha J., Murphy S.A., James D., Morrow D.A., Cannon C.P., Giugliano R.P., Antman E.M., Braunwald E., and TIMI Study Group. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the thrombolysis in myocardial infarction trials. J Am Coll Cardiol 42 (2003) 7-16
8. Scheller B., Hennen B., Hammer B., Walle J., Hofer C., Hilpert V., Winter H., Nickenig G., Böhm M., and SIAM III Study Group. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol 42 (2003) 634-641
9. Fernandez-Avilés F., Alonso J.J., Castro-Beiras A., Vázquez N., Blanco J., Alonso-Briales J., López-Mesa J., Fernández-Vazquez F., Calvo I., Martínez-Elbal L., San Román J.A., Ramos B., and GRACIA Group. Routine invasive strategy within 24 hours after thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomized controlled trial. Lancet 363 (2004) 1045-1053
10. Steg P.G., Bonnefoy E., Chabaud S., Lapostolle F., Dubien P.Y., Cristofini P., Leizorovicz A., and Touboul P. Comparison of Angioplasty and Prehospital Thrombolysis In acute Myocardial infarction (CAPTIM) Investigators. Impact of time to treatment on mortality after prehospital fibrinolysisor primary angioplasty: data from CAPTIM randomized clinical trial. Circulation 108 (2003) 2851-2856
11. Armstrong P.W., and WEST Steering Committee. A comparison of pharmacologic therapy with/without timely coronary intervention vs primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) Study. Eur Heart J 27 (2006) 1530-1538
12. Collet J.P., Montalescot G., Le May M., Borentain M., and Gershlick A. Percutaneous coronary intervention after fibrinolysis. A multiple meta-analysis approach to the type of strategy. J Am Coll Cardiol 48 (2006) 1326-1335
13. De Luca G., Suryapranata H., Stone G.W., Antoniucci D., Tcheng J.E., Neumann F.J., Van de Werf F., Antman E.M., and Topol E.J. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction. A meta-analysis of randomized trials. JAMA 293 (2005) 1759-1765
14. Montalescot G., Borentain M., Payot L., Collet J.P., and Thomas D. Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis. JAMA 292 (2004) 362-366
15. Topol E.J., Neumann F.J., and Montalescot G. A preferred reperfusion strategy for acute myocardial infarction. J Am Coll Cardiol 342 (2003) 1186-1189
16. Assessment of the Safety and Efficacy of a New Treatment strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) Investigators. Primary vs tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomized trial. Lancet 367 (2006) 569-578
17. Fernandez-Aviles F., Alonso J.J., Pena G., Blanco J., Alonso-Briales J., López-Mesa J., Fernández-Vázquez F., Moreu J., Hernández R.A., Castro-Beiras A., et al., GRACIA-2 Investigators. Primary angioplasty vs early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA 2 non-inferiority, randomized, controlled trial. Eur Heart J 28 (2007) 949-960
18. Agati L., Funaro S., Madonna M., Sardella G., Garramone B., and Galiuto L. Does coronary angioplasty after timely thrombolysis improve microvascular perfusion and left ventricular function after acute myocardial infarction?. Am Heart J 154 (2007) 151-157
19. Verheugt F.W.A. Lyse now, stent later: the grace of GRACIA. Lancet 364 (2004) 1014-1015